Security
Greenwich LifeSciences, Inc. Common Stock · GLSI
GLSINASDAQCommon stockCurrentCIK 1799788Updated Oct 27, 2026
GLSI price & chart
Loading TradingView…
NASDAQ:GLSI on TradingView ↗In the news
Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom ↗
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Greenwich LifeSciences, Inc. (NASDAQ: GLSI) News provided by Purcell & Lefkowitz LLP Feb 11, 2025, 10:06 ET Share this article Share to X Share this article Share to X NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Purcell & ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 3,806,978Source | 5,825,049Source | 8,876,353Source | 3,125,101Source | 7,228,460Source | 10,505,435Source | 2,750,835Source | 5,510,463Source | 6,178,021Source | 4,093,769Source | 6,994,815Source | 13,477,029Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 3,806,978Source | 5,822,367Source | — | 3,125,101Source | 7,224,875Source | — | 2,749,959Source | 5,505,975Source | 6,178,021Source | 4,091,990Source | 6,989,424Source | 13,468,026Source |
| Assets, CurrentUSD | — | — | 8,876,353Source | — | — | 10,505,435Source | — | — | 6,178,021Source | — | — | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,622,001Source | 842,384Source | 5,759,396Source | 1,685,609Source | 1,353,028Source | 5,235,229Source | 1,438,524Source | 389,611Source | 5,824,804Source | 1,559,733Source | 294,406Source | 262,905Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 13,795Source | 13,145Source | 14,678Source | 13,473Source | 13,068Source | 14,666Source | 13,193Source | 12,876Source | 14,299Source | 13,153Source | 12,848Source | 12,848Source |
| Retained Earnings (Accumulated Deficit)USD | -77,588,863Source | -58,113,159Source | -96,742,818Source | -73,437,018Source | -55,444,446Source | -92,794,143Source | -69,411,740Source | -52,837,764Source | -87,137,006Source | -66,153,378Source | -50,364,569Source | -41,472,766Source |
| Stockholders' Equity Attributable to ParentUSD | 2,184,977Source | 4,982,665Source | 3,116,957Source | 604,302Source | 5,875,432Source | 5,270,206Source | 200,483Source | 5,120,852Source | 353,217Source | 2,534,036Source | 6,700,409Source | 13,214,124Source |
| Additional Paid in Capital, Common StockUSD | 79,760,045Source | 63,082,679Source | 99,845,097Source | 74,863,037Source | 61,306,810Source | 98,049,683Source | 70,710,858Source | 57,945,740Source | 87,475,924Source | 68,674,261Source | 57,052,130Source | 54,674,042Source |
| Liabilities and EquityUSD | 3,806,978Source | 5,825,049Source | 8,876,353Source | 3,125,101Source | 7,228,460Source | 10,505,435Source | 2,750,835Source | 5,510,463Source | 6,178,021Source | 4,093,769Source | 6,994,815Source | 13,477,029Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 1,622,001Source | 842,384Source | 5,759,396Source | 1,685,609Source | 1,353,028Source | 5,235,229Source | 1,438,524Source | 389,611Source | 5,824,804Source | 1,559,733Source | 294,406Source | 262,905Source |
| Accounts Payable, Current | — | —Source | —Source | — | — | —Source | —Source | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 1,544,214Source | 1,544,214Source | 6,803,325Source | 7,253,327Source | 2,378,088Source | 1,743,865Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -365,461Source | -643,237Source | 2,071,543Source | 921,219Source | 35,472Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -4,702,498Source | -1,834,454Source | -9,913,453Source | -7,266,543Source | -6,478,602Source | -6,200,027Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 7,536,216Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 9,029,912Source | 492,423Source | 11,999,484Source | 4,369,109Source | — | -7,536,216Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 4,327,414Source | -1,342,031Source | 2,086,031Source | -2,897,434Source | -6,478,602Source | -13,736,243Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 3,806,978Source | 5,822,367Source | 8,876,353Source | 3,125,101Source | 10,505,435Source | 2,749,959Source | 6,178,021Source | 4,091,990Source | — | — |
| Additional Financial Items | ||||||||||||
| AmortizationUSD | — | — | — | — | — | — | — | 903Source | 1,779Source | 3,612Source | 3,612Source | 3,612Source |
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 3,626,584Source | — |
| General and Administrative ExpenseUSD | — | — | 653,066Source | 437,011Source | 462,931Source | 352,838Source | 518,190Source | 497,602Source | 2,227,517Source | 3,059,788Source | 1,629,244Source | 1,564,586Source |
| Investment Income, InterestUSD | — | — | 22,797Source | 60,338Source | 72,970Source | 20,675Source | 68,617Source | 23,970Source | 89,700Source | 223,008Source | 436,063Source | 215,017Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -4,151,845Source | -2,668,713Source | -3,948,675Source | -3,748,640Source | -5,657,137Source | -2,744,780Source | -19,358,218Source | -15,788,809Source | -8,891,803Source | -7,825,237Source |
| Operating ExpensesUSD | — | — | 4,174,642Source | 2,729,051Source | 4,021,645Source | 3,769,315Source | 5,725,754Source | 2,768,750Source | 19,447,918Source | 16,011,817Source | 9,327,866Source | 8,040,254Source |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Proceeds from Issuance of Common Stock | — | — | — | — | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -4,174,642Source | -2,729,051Source | -4,021,645Source | -3,769,315Source | -5,725,754Source | -2,768,750Source | -19,447,918Source | -16,011,817Source | -9,327,866Source | -8,040,254Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -4,151,845Source | -2,668,713Source | -3,948,675Source | -3,748,640Source | -5,657,137Source | -2,744,780Source | -19,358,218Source | -15,788,809Source | -8,891,803Source | -7,825,237Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.3Source | -0.2Source | -0.27Source | -0.28Source | -0.39Source | -0.21Source | -1.43Source | -1.21Source | -0.69Source | -0.61Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.3Source | -0.2Source | -0.27Source | -0.28Source | -0.39Source | -0.21Source | -1.43Source | -1.21Source | -0.69Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 13,641,384Source | 13,142,457Source | 14,621,230Source | 13,370,983Source | 14,565,230Source | 13,171,555Source | 13,534,994Source | 13,014,585Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 13,641,384Source | 13,142,457Source | 14,621,230Source | 13,370,983Source | 14,565,230Source | 13,171,555Source | 13,534,994Source | 13,014,585Source | 12,848,165Source | — |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | — | 653,066Source | 437,011Source | 462,931Source | 352,838Source | 518,190Source | 497,602Source | 2,227,517Source | 3,059,788Source | 1,629,244Source | 1,564,586Source |
| Investment Income, InterestUSD | — | — | 22,797Source | 60,338Source | 72,970Source | 20,675Source | 68,617Source | 23,970Source | 89,700Source | 223,008Source | 436,063Source | 215,017Source |
| Operating ExpensesUSD | — | — | 4,174,642Source | 2,729,051Source | 4,021,645Source | 3,769,315Source | 5,725,754Source | 2,768,750Source | 19,447,918Source | 16,011,817Source | 9,327,866Source | 8,040,254Source |
| Research and Development ExpenseUSD | — | — | 3,521,576Source | 2,292,040Source | 3,558,714Source | 3,416,477Source | 5,207,564Source | 2,271,148Source | 17,220,401Source | 12,952,029Source | 7,698,622Source | 6,475,668Source |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | — | — | — | — | —Source | —Source | — | — | — | — |